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Gold  nanoparticles  (GNPs)  have  numerous  medical  applications  as  in  biological  imaging,
cancer  treatment  and  in implants  (pacemakers  and  stents).  Many  conﬂicting  results  about
GNPs safety  and its  accumulation  in liver,  kidney  and  brain  were  recorded.  This work  was
carried out  to  study  the  histological  effect  of long  period  exposure  to gold  nanoparticle  on
the  brain  of  adult  male  albino  rat. Twenty  adult male  albino  rats  were  divided  into  two  equal
groups:  The  ﬁrst  one  served  as a control  group  and  the  second  one  received  400  g/kg/day
GNPs  by gastric  tube  once  daily  for  eight  weeks.  Brain  specimens  were collected  at the  end
of the  experiment  for histological  and immunohistochemical  studies  using  caspase-3  and
glial  ﬁbrillary  acidic  protein  (GFAP).  GNPs  treated  group  revealed  wide  spread  histological
alterations  and deposition  of gold  nanoparticle  aggregates  in the  neurons  of  cerebral  cortex
and  hippocampus  and  also  in the  epithelium  of  choroid  plexus  with  hyalinization  of the  wall
of some  blood  vessels  and  disruption  of the  capillaries.  All these  changes  were  associated
with  localized  positive  caspase  3 reaction.  Various  degrees  of  astrogliosis  were  evidenced
by  astrocytic  proliferation  and increase  size  of their  cell  body  with  increase  number  and
length of their  processes.  It could  be concluded  that  repeated  exposure  of  adult  male  albino
rats to gold  nanoparticles  induced  its deposition  in  the  brain  in  association  with  histological
alterations  and  various  degrees  of  astrogliosis.
©  2015  Saudi  Society  of  Microscopes.  Published  by  Elsevier  Ltd.  All  rights  reserved.. Introduction
Cancer can be treated by various lines of treatment
ncluding surgery, chemo, radio and immunotherapy.
ecently nanotechnology holds the promise of treating
ancer using lower concentrations of chemotherapeutic
gents and target malignant cells while leaving healthy
ells untouched [1].
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is less than 100 nanometers, approximately 100,000 times
smaller than the diameter of a human hair. Nano-sized
particles exist in nature and can be created from carbon
or minerals like silver and gold. Creating and engineering
materials to such a small scale, allow them to acquire on
unique therapeutic, electrical and optical properties [2,3].
Gold nanoparticle biomolecule (GNPs) are largely used
as bio-markers and biodelivery vehicles in the medicine,
pharmacy and in cosmetic products [4,5]. Nano-sized par-
ticles can enter the human body through inhalation and
ingestion and through the skin [2]. Orally administrated
ghts reserved.
roscopy
counted and measured. Counting and morphometric anal-
ysis were carried out in EM unit of Faculty of medicine182 E.A.E.A. El-Drieny et al. / Journal of Mic
GNPs appeared in various tissues in mice and the amount
of absorption and distribution in the body inversely cor-
related with the size of the particles [6]. In most studies,
systemically administrated NPs were primarily taken up
by liver and spleen in a large quantity and small amounts
distributed in the lung, kidney, heart, and brain after single
administration [6,7].
However, for the therapeutic application and drug deliv-
ery of GNPs it is essential to know the distribution and local
or systemic toxicity associated with them and whether
they have the ability to cross the blood–brain barrier to
reach the nervous tissue or not. For this purpose, this study
was carried out to assess the potential consequences of oral
administration gold nanoparticle on the brain of adult male
albino rat.
2. Materials and methods
2.1. Chemicals
2.1.1. Preparation of gold chloride nanoparticles (GNPs)
GNPs (15 nm size) were synthesized according to
Levy et al. [8] by citrate reduction of chloroauric acid
(HAuCl4). This causes gold(III) auric (Au3+) ions to
be reduced to neutral gold atoms. As much of these
gold atoms form, the solution becomes supersaturated,
and gold gradually precipitated in the form of sub-
nanometer particles. The colloidal GNPs solution was
ﬁltered through 0.45 m Millipore syringe ﬁlters to get
rid of any precipitate; the pH was adjusted to 7 using
dilute NaOH solution, and the ﬁltrate was stored at 4 ◦C
[8,9].
During the synthesis of GNPs, a 1 nM solution was  pre-
pared. To obtain the desired dose, 10 ml  of the 1 nM solution
was centrifuged at 13,500 rpm for 10 min  and the obtained
pellet was re-suspended in sodium citrate 1.2 mM to obtain
10 nM (110 g of gold/ml). The solution was dark red in
color. Gold nanoparticle characterization was carried by
spectrophotometer and transmission electron microscopy
[9].
Spectrophotometry is used to identify gold nanoparti-
cles in the prepared solutions. The electronic UV-Visible
absorption spectrum was recorded on a Perkin Elmer
lambda-17 spectrophotometer using a quartz cell with a
path length of 1 cm.  Spectrophotometry of gold nanoparti-
cles showed strong light absorption in the visible region
of the optical spectrum with a maximum of absorbance
centered at 520 nm.
Transmission electron microscopy (TEM, Hitachi HU-
11B) at 80 kV was used to determine the size and shape of
GNPs. The aqueous solution of gold nanoparticle was  drop
cast onto a carbon coated copper grid, and the grid was air
dried at room temperature. The grids loaded with nanopar-
ticles were examined by electron microscope. Quantitative
analysis of nanoparticles size was performed by measuring
the core diameter of 200 individual particles from multiple
micrographs. All these procedures were carried in National
Institute of Laser Enhanced Sciences – Cairo University. The
prepared gold nanoparticles were spherical in shape and
about 15 nm in size. and Ultrastructure 3 (2015) 181–190
2.2. Animals
This work was  carried out on 20 adult male albino rats
weighing 180–200 g. Experimental protocol was approved
by the local ethical Committee of Faculty of Medicine, Tanta
University, Egypt prior to the study and the animal care
was  carried out according to the national guidelines for
animal care. Drinking water and conventional food were
provided ad libitum. Animals were divided into two equal
groups. The ﬁrst one served as a control group and kept
without treatment throughout the whole period of the
experiment. The second one served as an experimental
group and received orally 400 g/kg/day for 8 weeks of
solutions of 110 g of gold NPs/ml by gastric tube [6]. At
the end of the eight weeks, animals were anesthetized and
decapitated and the brain was harvested by careful rapid
dissection and was immediately ﬁxed in 4% paraformalde-
hyde for both histological and immunohistochemical
study.
2.3. Histological and Immunohistochemical study
For histological study, coronal brain sections were cut
and processed for parafﬁn sections of 5 m thickness to be
stained with Hematoxylin and Eosin [10].
Immunohistochemical detection of caspase-3 and Glial
ﬁbrillary acidic protein (GFAP) were performed using pri-
mary rabbit anti-rat caspase-3 antibody and primary rabbit
anti-GFAP antibody respectively from Neo Markers Fre-
mont CA, Lab Vision. The avidin–biotin complex technique
was  used. Positive reaction for caspase 3 was visualized
as brown coloration of the cytoplasm of the neural cells,
while positive reaction for Glial ﬁbrillary acidic protein was
visualized as brown coloration of the astrocytes including
their bodies and their processes. Negative controls were
done using the same steps except that phosphate buffered
saline was  applied instead of the primary antibodies [11].
All these procedures were carried in the Histology Depart-
ment of Faculty of Medicine Tanta University.
2.4. Quantitative evaluation of immunolabeled sections
Each immunolabeled section was  observed at 400×
magniﬁcation. The number of caspase 3 positive neurons
was  recorded in the cerebral cortex, hippocampus and in
the choroidal plexus in 10 nonoverlapping ﬁelds in slides
of each animal of each group. Also, the number of GFAP
positive cells was  recorded in the cerebral cortex and hip-
pocampus in 10 nonoverlapping ﬁelds in slides of each
animal of each group. Only process-bearing astrocytes with
their nuclei in the plane of the section were considered.
Also the number of astrocytic processes, the diameter of
astrocytic cell bodies, and the length of the processes wereTanta University using image J 1.47 software (Wayne Ras-
band, USA). All data were analyzed using Student’s t-test
for comparison of the means, taking P < 0.05 as signiﬁcance
level [12].
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eig. 1. Showing six layers of cerebral cortex of control group; molecular 
IV),  inner pyramidal layer (V) and polymorphic layer (VI). These layers
ucleoli (→) of the neurons and also of neuroglial cells without properly 
. Results
.1. Histological results.1.1. Hematoxylin and eosin
Light microscopic examination of hematoxylin and
osin stained sections of cerebral cortex of adult male
Fig. 2. Brain of control group showing large (A) and medium sized blood ves, outer granular layer (II), outer pyramidal layer (III), inner granular layer
g acidophilic neuropile and rounded open face nuclei with prominent
oplasm (). H&E, (A) ×100; (B) H&E, ×400.
albino rat of control group revealed six distinguished lay-
ers with no sharp boundaries in association small blood
vessels in between. These layers were; plexiform layer of
ﬁbers traveling parallel to the surface with relatively few
cells, external granular layer, small pyramidal cell layer,
inner granular layer, inner layer of large pyramidal cells
and ﬁnally the layer of polymorphic cells (Fig. 1). The
sel (B) and continuous wall of blood capillaries (→) (C). H&E, ×1000.
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3.1.2. Immunohistochemical study
The control group (group I) revealed negative immuno-
staining reaction for caspase-3 in all areas of the cerebralFig. 3. Hippocampus of control brain with its characteristic three layer:
polymorphic layer (1), pyramidal layer (2) and the molecular layer (3).
H&E, ×1000.
neuronal cells of all these areas contain oval or rounded
open face nuclei with prominent nucleoli surrounded by
basophilic cytoplasm. In the neuropile of these layers, many
blood vessels of different sizes were seen together with
nuclei of neuroglial cells without properly seen cytoplasm
(Fig. 2). High power examination of hippocampus revealed
three layer; molecular, pyramidal and polymorphic layers
(Fig. 3). The choroid plexus consisted of a layer of cuboidal
epithelial cells (ependymal cells) surrounding a core of
capillaries and loose connective tissue (Fig. 4).
The gold nanoparticle treated group (group II) revealed
brown deposits in the neuropile of the cerebral cortex
(Fig. 5) and also in the hippocampus (Fig. 6). Also some
neuronal cells appeared darkly stained irregular, distorted
and shrunken with pericellular haloes together with darkly
stained nuclei (Figs. 5 and 6). Brain of GNPs treated group
showed large sized and medium sized BV with hyaliniza-
tion and GNPs deposition in their wall. The blood capillaries
revealed disruption of their wall (Fig. 7). The cytoplasm
Fig. 4. Choroid plexus of brain of control group showing ependymal cells
(→)  surrounding blood capillaries (C). H&E, ×1000.Fig. 5. Cerebral cortex of gold nanoparticle treated group showing aggre-
gates of gold nanoparticles in the neuropile of the cerebral cortex (→)
together with distorted darkly stained neurons with darkly stained nuclei
() and intracytoplasmic vacuoles (V). H&E, ×1000.
of some ependymal cells of the choroids displayed brown
deposits (Fig. 8).Fig. 6. Hippocampus with its characteristic three layers) polymorphic 1,
pyramidal 2 and molecular 3 (of gold nanoparticle treated group show-
ing aggregates of gold nanoparticles in the neuropile (→). Some neuronal
cells appeared darkly stained shrunken with per cellular’ haloes (). H&E,
×1000.
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×ig. 7. Brain of GNPs treated group showing large sized BV (A) and med
isruption of the wall of blood capillaries (C&D) (→). H&E, ×1000.
ortex (Fig. 9A) and also in the hippocampus (Fig. 9B). The
horoid showed few localized mildly positive choroidal
pithelial cells for active caspase 3 (Fig. 10). Similarly, gold
anoparticle treated animals revealed negative caspase 3
eaction in the cerebral cortex and only few positive neu-
ons were seen in the hippocampus (Fig. 11). On the other
and, choroidal epithelium of the same group showed
trong positive reaction for active caspase-3 in many cells
Fig. 12).
ig. 8. Choroidal plexus of gold nanoparticle treated group showing
rown deposits of GNPs in the cytoplasm of ependymal cells (→). H&E,
1000.ed BV (B) with hyalinization of their walls and GNPs deposition. Notice
Cerebral cortex and hippocampus of the control group
showed widely apart small sized GFAP positives astro-
cytes with few short process (Fig. 13). The GNPs treated
group showed different degrees of astrogliosis. This was
in the form of astrocytic proliferation and increase size of
their cell body with increase number and length of their
processes. Some areas of cerebral cortex displayed moder-
ate astrogliosis manifested by preservation of individual
astrocyte and without pronounced overlap of astrocyte
processes (Fig. 14A). Other areas displayed diffuse reactive
astrogliosis evidenced by pronounced overlap of astro-
cyte processes with strong expression for GFAP (Fig. 15A).
Also the hippocampus revealed strong immunoreaction
and hypertrophy of astrocytes with different degree of
astrogliosis (Figs. 14B and 15B).
3.2. Morphometric and statistical analysis
No signiﬁcant difference in the number of caspase 3 pos-
itive neurons in the GNPS treated group compared with
control group as regard cerebral cortex and hippocampus.
However, there was signiﬁcant increase in the caspase 3
positive immunoreaction of the choroidal epithelium cells
in the GNPS treated group (Table 1). Morphometric analy-
sis revealed that the number of immunoreactive astrocytes
in the control group was more numerous in hippocampus
more than cerebral cortex. Signiﬁcant increase in the GFAP-
immunoreactive astrocytes was  also observed in the brain
of gold nano particles treated group in comparison to con-
trol group with speciﬁc predominance in the hippocampus
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Fig. 9. Cerebral cortex (A) and hippocampus (B) of brain of control group showing negative immune reaction for caspase-3. Caspase 3 immunostaining,
×1000.Fig. 10. Choroid plexus of control group showing few mildly positive cells
for active caspase-3 in the choroid epithelial cell. Caspase 3 immunostain-
ing, ×1000.
Table 1
Mean value of number of caspase-3 positive cells and GFAP positive astrocytes in
Measured parameters Control 
Number of caspase-3 positive neurons in cerebral cortex 0.75 ± 
Number of caspase-3 positive neurons in hippocampus 1.26 ± 
Number of caspase-3 positive cells in choroidal epithelium 1.86 ± 
Number of GFAP positive astrocytes in cerebral cortex 7.083 ± 
Number of GFAP positive astrocytes in hippocampus 11.75 ± 
Data expressed as mean ± standard deviation, t = Student (t) test, P value = probabFig. 11. Hippocampus of GNPs treated group showing positive neuron for
active caspase 3 (→). Caspase 3 immunostaining, ×1000.
 cerebral cortex and hippocampus of the studied groups.
GNPs group “t” value P value
0.45 0.833 ± 0.577 0.394 0.698
0.703 1.46 ± 0.516 0.887 0.382
0.351 5.133 ± 1.407 8.72 0.000
1.76 12.028 ± 3.24 6.79 0.003
2.251 17.25 ± 2.712 4.413 0.001
ility of chance, P < 0.05 is signiﬁcant.
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taining, ×1000.
ompared to cerebral cortex (Table 1). Similarly the diam-
ters of astrocyte cell bodies, the length and the numbers
f their processes were signiﬁcantly increased in the brain
f GNPs treated group compared to control one (Table 2).. Discussion
The present study demonstrated that gold nanoparti-
les administration displayed histological alterations in the
ig. 13. Cerebral cortex (A) hippocampus (B) of control group showing few wid
→).  GFAP immunostaining, ×1000. and Ultrastructure 3 (2015) 181–190 187
neurons of the cerebral cortex and in the hippocampus in
association with brown deposits in their cells and neuropile
and in the choroidal epithelium. All these changes were
associated with positive caspase 3 reaction in few neurons
and in the choroidal epithelium with different degrees of
astrogliosis.
The presence of GNPs in the brain tissue was simi-
lar to several previously reported publications like Hyllier
and Albertch [13] who  observed GNPs (from 4 to 58 nm)
in various tissues of mice including brain after single
oral administration. Others investigators [14] performed
a kinetic study to evaluate the GNPs size (10, 50, 100
and 250 nm)  effects on the in vivo tissue distribution of
nanoparticles in the rat 24 h after injection. The authors
showed that the tissue distribution of GNPs is size depend-
ent with the smallest 10 nm gold nanoparticles possessing
the most widespread organ distribution, whereas no GNP
was detected for larger 50 nm.  Reports have shown that
GNPs appear in various tissues after one and seven days of
intravenous administration [15]. Similar results have been
obtained with repeated intraperitoneal administration of
12.5 nm GNPs in mice once daily for eight weeks [6].
The presence of gold nanoparticles in the brain of GNPs
treated group and in the wall of the blood vessels as
presented in this study were attributed to two  different
mechanisms, ﬁrstly by transsynaptic transport after inhala-
tion through the olfactory epithelium, and secondly by its
uptake through the blood–brain barrier after its translo-
cation from the lung into the blood resulting in systemic
exposure of brain [16,17]. Some studies indicated that the
healthy BBB contains defense mechanisms protecting it
from blood borne nanoparticle exposure. When nanoparti-
cles with different surface characteristics were assessed,
ely apart small sized GFAP positive astrocytes with few short processes
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Fig. 14. Cerebral cortex (A) and hippocampus (B) of GNPs treated group showing strongly positive GFAP hypertrophic astrocytes with multiple elongated
processes (→) (moderate astrogliosis). GFAP immunostaining, ×1000.
showingFig. 15. Cerebral cortex (A) and hippocampus (B) of GNPs treated group 
GFAP immunostaining, ×1000.
neutral nanoparticles and low concentrations of anionic
nanoparticles were detected to have no result on BBB
integrity, while on the contrary high concentrations of
anionic nanoparticles and cationic nanoparticles were toxic
to the BBB [18]. Alzheimer’s like pathology was  recorded
in the brain and it was attributed to increased markers of
Table 2
Mean values of diameter of the astrocytes cell bodies and length and number of th
Measured parameters Control 
Diameter of cell body in m Mean ± SD 14.63 ± 3.18 
Length  of foot processes in mMean ± SD 17.52 ± 4.98 
Number of foot processes Mean ± SD 3.27 ± 0.64 
Data expressed as mean ± standard deviation, t = Student (t) test, P value = probab strong GFAP reaction and hypertrophic astrocytes (severe astrogliosis).
inﬂammation and accumulation of 42-amino acid form of
beta-amyloid (Abeta42) in frontal cortex and hippocampus
in association with the presence of nanoparticles [19].
Previous studies demonstrated that intravenously
administered gold nanoparticles to mice could pass
through the blood retinal barrier and are distributed in
eir processes in the brain of control and gold nanoparticle treated groups.
GNPs group “t” value P value
20.74 ± 4.12 2.370 0.033
32.37 ± 7.32 5.519 0.001
4.9 ± 0.83 5.153 0.001
ility of chance, P < 0.05 is signiﬁcant.
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ll retinal layers without cytotoxicity. It was also found
hat 20 nm membrane bound nanoparticles in the reti-
al neurons, endothelial cells and peri-endothelial glial
ells [20]. In the retina, cells containing nanoparticles did
ot show any structural abnormality and increase of cell
eath compared to cells without nanoparticles. Histologic
isualization of GNPs within the brain parenchyma was
eported previously suggesting BBB transgression [21].
anoparticle-associated toxicity degrade the BBB which
ay  be a factor contributing to nanoparticle access to the
rain parenchyma [4].
The morphological changes observed in present work
ere parallel to the previously reported data of previous
esearchers who  observed moderate hyperemia, pericellu-
ar edema, and weak neuronal degeneration in the brain
issue of rats. But the same study did not observe any
athological changes in the brain tissue of rabbits [22]. In
onsistence with these ﬁndings, Fernanda et al. [23] fol-
owed the biodistribution of GNPs in mice up to 7 days
fter intravenous injection of the nanoparticles with near
nfrared time-domain imaging. They detected the peak
oncentration in the head of mice was between 19 and 24 h.
he precise particle distribution in the brain was mainly
ccumulated in the hippocampus, thalamus, hypothala-
us, and the cerebral cortex [23]. This was contradictory
o the work of some investigators [18] who mentioned
hat both 50 and 15 nm NPs expressed histological changes
n the inner organs except for brain where the structural
hanges were not signiﬁcant and not size dependent. Sim-
larly, other studies could not demonstrate cytotoxicity in
he retina of mice [20] or brain of rat [6] after exposure to
NP. The reason for this difference between our study and
he results of others were not apparent, but could be related
o the size, shape, surface chemistry, synthesis methods,
urface composition of the nanoparticle, duration of expo-
ure and higher concentrations of gold nanoparticle used
24].
Several possible mechanisms for the toxicity of particles
n general have been postulated including injury of epithe-
ial tissue [25], inﬂammation, oxidative stress response
26,27], and allergy [28]. At the cellular level oxidative
tress is considered to be of importance [29]. Inﬂamma-
ory biomarkers such as Interleukin 1 (IL1) and Tumor
ecrosis Factor  (TNF) were increased in the brain of
ice exposed to ambient air particulate matter compared
o controls [30,31]. Nanoparticles have been shown to pro-
uce reactive oxygen species and oxidative stress [26].
rain is particularly susceptible to oxidative stress because
f its high oxygen consumption rate, it is rich in unsat-
rated lipids, and it has a relatively high abundance of
edox-capable transition metal ions and a relatively low
vailability of antioxidant enzymes compared with other
rgans [32]. In a previous study it was concluded that GNPs
ause generation of oxidative stress and an impairment of
he antioxidant enzyme glutathione peroxidase in rat brain.
NPs also cause generation of 8-hydroxydeoxyguanosine
8OHdG), caspase-3 and heat shock protein 70 (Hsp70),
nd IFN-, which may  lead to inﬂammation and DNA dam-
ge/cell death [31].
Astrogliosis was one of the prominent observed ﬁnd-
ng in the present study. Damaged neurons have long and Ultrastructure 3 (2015) 181–190 189
been reported to induce astrogliosis. Astrogliosis has been
used as an index for underlying neuronal damage. The
mechanism of triggering astrogliosis was attributed to
many different types of intercellular signaling molecules
including cytokines such as IL6, TNF, INF, TGF, FGF2,
etc., reactive oxygen species (ROS) including nitric oxide
(NO), mediators of innate immunity such as lipopolysac-
charide (LPS), neurotransmitters such as glutamate and
noradrenaline, purines such as ATP, hypoxia and glucose
deprivation, products associated with neurodegeneration
such as -amyloid and regulators of cell proliferation
such endothelin-1. Such molecular mediators of reac-
tive astrogliosis can be released by all cell types in
CNS tissue, including neurons, oligodendrocyte lineage
cells, microglia, endothelia, pericytes, and other astrocytes
[33–35]. The potential for 4 nm coated gold nanoparti-
cles was  investigated to act as selective carriers across
human brain endothelium and subsequently to enter astro-
cytes. Movement of these nanoparticles occurred across the
apical and basal plasma membranes via the cytosol with
relatively little vesicular or paracellular migration; antibi-
otics that interfere with vesicular transport did not block
migration. The transfer rate was also based on the surface
coating of the nanoparticle and incubation temperature.
Using a novel 3-dimensional co-culture system, which
includes primary human astrocytes and a brain endothe-
lial cell line hCMEC/D3, it has been demonstrated that
the glucose-coated nanoparticles traverse the endothe-
lium, move through the extracellular matrix and localize
in astrocytes [36].
5. Conclusions
It could be concluded that repeated exposure of adult
male albino rats to gold nanoparticles induced its depo-
sition in various areas of the brain in association with
histological alterations and various degrees of astrogliosis.
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